Evidence map›Paper›PMID 30091979›Full record

Trial reportPLoS neglected tropical diseases2018

Dynamic changes in human-gut microbiome in relation to a placebo-controlled anthelminthic trial in Indonesia.

Ivonne Martin, Yenny Djuardi, Erliyani Sartono, Bruce A Rosa, Taniawati Supali, Makedonka Mitreva, Jeanine J Houwing-Duistermaat, Maria Yazdanbakhsh

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Anthelmintic drugs for treating ascariasis.The Cochrane database of systematic reviews · 2020
    Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Food and waterborne parasitology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Ivonne MartinDepartment of Mathematics, Faculty of Information Technology and Science, Parahyangan Catholic University, Bandung, Indonesia.ORCID 0000-0003-0362-4479
Yenny DjuardiDepartment of Parasitology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Erliyani SartonoDepartment of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
Bruce A RosaMcDonnell Genome Institute at Washington University, St. Louis, Missouri, United States of America.
Taniawati SupaliDepartment of Parasitology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
Makedonka MitrevaMcDonnell Genome Institute at Washington University, St. Louis, Missouri, United States of America.
Jeanine J Houwing-DuistermaatDepartment of Statistics, University of Leeds, Leeds, United Kingdom.
Maria YazdanbakhshDepartment of Parasitology, Leiden University Medical Centre, Leiden, The Netherlands.
James S. McDonnell Foundation · USLeiden University · NLUniversity of Indonesia · IDParahyangan Catholic University · IDUniversity of Leeds · GB

Funding

Large Scale Genome SequencingU54HG003079 · NHGRI · WASHINGTON UNIVERSITY · PI DUTCHER, SUSAN K · 2004 to 2016
$445.7M
COMPARATIVE GENOMICS OF PARASITIC NEMATODESR01AI081803 · NIAID · WASHINGTON UNIVERSITY · PI MITREVA, MAKEDONKA · 2009 to 2018
$3.1M
COMPARATIVE GENOMICS OF PARASITIC NEMATODESR56AI081803 · NIAID · WASHINGTON UNIVERSITY · PI MITREVA, MAKEDONKA · 2019 to 2019
$697k
NHGRI NIH HHS U54 HG003079NIAID NIH HHS R01 AI081803NIAID NIH HHS R56 AI081803
6 · The paper itself

Abstract

backgroundMicrobiome studies suggest the presence of an interaction between the human gut microbiome and soil-transmitted helminth. Upon deworming, a complex interaction between the anthelminthic drug, helminths and microbiome composition might occur. To dissect this, we analyse the changes that take place in the gut bacteria profiles in samples from a double blind placebo controlled trial conducted in an area endemic for soil transmitted helminths in Indonesia.

methodsEither placebo or albendazole were given every three months for a period of one and a half years. Helminth infection was assessed before and at 3 months after the last treatment round. In 150 subjects, the bacteria were profiled using the 454 pyrosequencing. Statistical analysis was performed cross-sectionally at pre-treatment to assess the effect of infection, and at post-treatment to determine the effect of infection and treatment on microbiome composition using the Dirichlet-multinomial regression model.

resultsAt a phylum level, at pre-treatment, no difference was seen in microbiome composition in terms of relative abundance between helminth-infected and uninfected subjects and at post-treatment, no differences were found in microbiome composition between albendazole and placebo group. However, in subjects who remained infected, there was a significant difference in the microbiome composition of those who had received albendazole and placebo. This difference was largely attributed to alteration of Bacteroidetes. Albendazole was more effective against Ascaris lumbricoides and hookworms but not against Trichuris trichiura, thus in those who remained infected after receiving albendazole, the helminth composition was dominated by T. trichiura. DISCUSSION: We found that overall, albendazole does not affect the microbiome composition. However, there is an interaction between treatment and helminths as in subjects who received albendazole and remained infected there was a significant alteration in Bacteroidetes. This helminth-albendazole interaction needs to be studied further to fully grasp the complexity of the effect of deworming on the microbiome.

trial registrationISRCTN Registy, ISRCTN83830814.

Indexed as

AdolescentAdultAlbendazoleAnthelminticsBacteriaChildDouble-Blind MethodFamily CharacteristicsFemaleGastrointestinal MicrobiomeHumansIndonesiaMaleRNA, BacterialRNA, Ribosomal, 16SYoung AdultAlbendazoleAnthelminticsRNA, BacterialRNA, Ribosomal, 16S

Identifiers

PMID30091979
PMCPMC6084808
OpenAlexW2885495225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.